Pharmacological Targeting of Integrated Oncogenic and Tumour Suppressive Pathways using Novel Therapeutics. [ 2014 - 2016 ]

Research Grant

Researchers: Prof Des Richardson (Principal investigator) ,  Dr Danuta Kalinowski ,  Dr Zaklina Kovacevic

Brief description We will investigate NDRG1, a novel molecular target that has been demonstrated to inhibit the progression of numerous cancers. We aim to better understand the underlying function of NDRG1 in pancreatic cancer and how we can potentially target this gene with novel therapeutics being developed in our lab. We hope that this new approach will lead to promising treatments and a better outcome for those suffering from pancreatic cancer.

Funding Amount $AUD 510,953.95

Funding Scheme Project Grants

Notes Standard Project Grant